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Multiple sclerosis (MS) is associated with loss of skeletal muscle mass and function. The
myogenic stem cells (satellite cells—SCs) are instrumental to accretion of myonuclei,
but remain to be investigated in MS. The present study aimed to compare the SC and
myonuclei content between MS patients (n = 23) and age matched healthy controls
(HC, n = 18). Furthermore, the effects of 12 weeks of high intensity training on SC and
myonuclei content were explored in MS. Muscle biopsies were obtained from m. Vastus
Lateralis at baseline (MS and HC) and following 12 weeks of training (MS only). Frozen
biopsies were sectioned followed by immunohistochemical analysis for fiber type specific
SCs (Pax7+), myonuclei (MN) and central nuclei content and fiber cross-sectional area
(fCSA) was quantified using ATPase histochemistry. At baseline the SCs per fiber was
lower in type II compared to type I fibers in both MS (119%, p < 0.01) and HC (69%, p <
0.05), whereas the SCs per fCSA was lower in type II fibers compared to type I only in MS
(72%, p < 0.05). No differences were observed in MN or central nuclei between MS and
HC. Following training the type II fiber SCs per fiber and per fCSA inMS patients increased
by 165% (p < 0.05) and 135% (p < 0.05), respectively. Furthermore, the type II fiber MN
content tended (p = 0.06) to be increased by 35% following training. In conclusion, the
SC content is lower in type II compared to type I fibers in both MS and HC. Furthermore,
high intensity training was observed to selectively increase the SC and myonuclei content
in type II fibers in MS patients.
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INTRODUCTION
Multiple sclerosis (MS) is a chronic disease of the central nervous system that is often accompanied
by a sedentary lifestyle (Miller and Dishon, 2006). This affects skeletal muscle characteristics in
these patients, as evidenced by reduced skeletal muscle fiber cross-sectional area (fCSA) andmuscle
mass of the lower limbs, leading to reduced muscle strength (Wens et al., 2014). In turn the reduced
muscle strength affects functional capacity and subsequently quality of life (Compston and Coles,
2002). Consequently, a thorough understanding of muscle biology is important to optimize the
preservation of muscle function and thereby functional capacity in MS.
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In this regard, an essential aspect of muscle repair, growth,
and remodeling is a functional population of quiescent muscle
specific stem cells, commonly referred to as satellite cells (SCs)
(Brack and Rando, 2012; Montarras et al., 2013; Yin et al.,
2013). Since the discovery and proposed role as a resident pool
of quiescent myogenic stem cells (Mauro, 1961), the SCs have
been shown to possess a critical role in animal skeletal muscle
regeneration (Lepper et al., 2011; von Maltzahn et al., 2013),
during which SCs are activated, proliferate, and differentiate to
support regeneration and new myofiber formation.
While the prerequisite for SCs during the initial phase of
myofiber growth is currently controversial (Adams et al., 2002;
Petrella et al., 2008; McCarthy et al., 2011; Sambasivan et al.,
2011; Guerci et al., 2012; Blaauw and Reggiani, 2014; Biressi
and Gopinath, 2015) the SCs become important for continued
myofiber growth at later stages (Fry et al., 2014a). These findings
in rodents are supported by a number of studies in healthy
human skeletal muscle reporting that the SC activity and content
increases following acute (i.e., hours-days) resistance exercise and
the SC content remains elevated following prolonged (i.e., weeks-
months) resistance training (Kadi et al., 2004; Olsen et al., 2006;
Petrella et al., 2008; Verdijk et al., 2009a; Mackey et al., 2010,
2011;McKay et al., 2012; Snijders et al., 2012, 2013). Interestingly,
conditional ablation of SCs in both young and old (sarcopenic)
mice is associated with increased fibroblast proliferation (Tcf4+
cells) and connective tissue content (fibrosis) (Fry et al., 2014a,
2015). In addition, co-culture experiments with primary cells
from mice skeletal muscle suggest that factors released from SCs
may also regulate adipogenic differentiation of fibro-adipogenic
progenitors during muscle regeneration (Uezumi et al., 2010).
Collectively, SC content and function may be important for
muscle hypertrophy as well as controlling and ensuring a healthy
muscle microenvironment (changes in fibrotic and adipocyte
content).
Both aging and disease may impair the capacity for SCs to
support myofiber regeneration (Conboy et al., 2005; Chakkalakal
et al., 2012; Cosgrove et al., 2014; Price et al., 2014), which
is ascribed to alterations in the SC niche or the systemic
environment (Conboy et al., 2005; Carlson et al., 2009;
Chakkalakal et al., 2012; Elabd et al., 2014; Sinha et al., 2014)
negatively influencing SC proliferation and differentiation. In
rodents, sarcopenia is not accelerated when SCs are ablated
(approximately 90% efficiency of SC ablation), however, loss of
SCs is associated with increased fibrosis (Fry et al., 2015), which
may compromisemuscle function. In humans, aging is associated
with a decrease in type II fiber size (Kryger and Andersen,
2007; Verdijk et al., 2009a; Suetta et al., 2013) and a preferential
reduction in SCs associated with type II fibers (Verdijk et al.,
2009a, 2013; Mackey et al., 2013). Moreover, the aging muscle
microenvironment is associated with increased fibrosis and
adipocyte infiltration (Conley et al., 1995; Mann et al., 2011).
In contrast to aging, there is sparse knowledge concerning the
SC content in humans suffering from chronic diseases. Studies
in type II diabetes (Snijders et al., 2011), chronic obstructive
pulmonary disorders (Theriault et al., 2014), rheumatoid arthritis
(Beenakker et al., 2012) or patients undergoing dialysis (Molsted
et al., 2015) does, however, not indicate a lower SC content in
these conditions, although further research is necessary. So far,
no studies have evaluated if a chronic neurological condition,
such as MS, affects SC content and the ability of the SCs to
proliferate and differentiate. Such knowledge is important in
order to identify and understand mechanisms underlying muscle
atrophy and dysfunction and to develop strategies to preserve
functional capacity and avoid muscle deterioration.
Resistance exercise has attracted much attention as it is
known to increase the fCSA of the type II fibers in healthy
subjects (Folland andWilliams, 2007; Verdijk et al., 2009a; Farup
et al., 2012) as well as in MS patients (Dalgas et al., 2010).
Following resistance exercise there is an increased proliferation
of SCs, specifically associated with type II fibers, in young, and
elderly individuals (Snijders et al., 2009; McKay et al., 2012).
Moreover, the type II fiber SC content remains increased in
elderly following prolonged resistance training (Verdijk et al.,
2009a). In addition to resistance exercise alone (Dalgas et al.,
2010) the combination of endurance and resistance exercise
improves various aspects of the physiological profile of MS
patients and may constitute the optimal exercise stimulus in
MS (Doring et al., 2011; Wens et al., 2015). Of note, endurance
exercise may also stimulate SC proliferation (Joanisse et al., 2013;
Fry et al., 2014b) although it is not yet clear if this proliferation is
fiber type specific. Taken together, fundamental questions related
to the effects of combined endurance and resistance exercise
on SC still needs to be addressed in pathological conditions
including MS.
This study set out to compare the SC content and the muscle
environment inMS patients and healthymatched controls as well
as to evaluate the effect of a 12-week training program consisting
of combined endurance and resistance training on SC content
in MS patients. It was hypothesized that the type II fiber SC
and myonuclei content was reduced in MS patients compared
to healthy controls and that the 12-week training program could
reverse this decline in SC and myonuclei content in type II fibers.
Furthermore, we hypothesized that MS patient’s skeletal muscle
would display an increased level of fibrosis and lipid content
[reflective of intramyocellular as well as intermyocellular (e.g.,
adipocytes) lipid content] compared to healthy age and activity
matched controls.
MATERIALS AND METHODS
Participants
Twenty-three MS patients diagnosed according to McDonald
criteria (Expanded disability status scale; range 1–6) and 18
matched healthy controls (HC), aged >18 years, were included
following written informed consent. Subjects were excluded if
they had other disorders (cancer, cardiovascular, pulmonary,
and/or renal), were pregnant, participated in another study,
had an acute MS-exacerbation 6 months prior to the start of
the study or contra-indications to perform physical exercise.
The study was approved by the Ethical committee at Hasselt
University and by the Ethical committee at Jessa Hospital
in Hasselt, and the study was registered at ClinicalTrials.gov
(NCT01845896). All study-procedures followed the Declaration
of Helsinki.
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Study Design Overview
At the start of the study knee flexor and extensor strength, body
composition, maximal endurance capacity, and self-reported
physical activity levels were assessed in MS patients (Wens et al.,
2014). Next, (separated by at least 48 h) m. Vastus Lateralis
muscle biopsies were collected from MS patients and HC.
Subjects were then randomized into one of two exercise groups
performing 12 weeks of a high intensity interval + resistance
training (HITR, n = 12) or high intensity continuous endurance
+ resistance training (HCTR, n = 11), respectively. Neither the
patients nor the researchers involved in the project were blinded
to group allocation. All testing was repeated after 12 weeks.
Exercise Intervention Program
After baseline measurements, the subjects were enrolled in a
well-controlled and supervised training program, to increase
cardiorespiratory fitness, as well as strength of the major
peripheral muscle groups. Subjects participated in five sessions
per 2 weeks. Training sessions were interspersed by at least 1 day
of rest, to ensure adequate recovery.
HITR Program
High intensity cycle interval training was performed during the
first 6 weeks where exercise duration gradually increased from
5 × 1min interspersed by 1min rest intervals to 5 × 2min
and 1min rest intervals. Exercise intensity was defined as the
heart rate, corresponding to 100% of the maximal workload
obtained during the initial incremental test. During the second
6 weeks, the exercise duration remained stable at 5 × 2 min
and the workload increased to reach a level corresponding to
100–120% of the maximal workload. The second part consisted
of moderate-to-high intensity resistance training (leg press, leg
curl, leg extension, vertical traction, arm curl, and chest press). In
order to exercise at similar relative workload, resistance training
of the lower limb was performed unilaterally, due to the frequent
bilateral strength differences seen between the legs of persons
with MS (Thoumie et al., 2005). Training intensity and volume
were adjusted from 1 × 10 repetitions to 2 × 20 repetitions at
maximal attainable load.
HCTR Program
Session duration and exercise intensity increased as the
intervention progressed, starting from 1 × 6min/session to 2 ×
10 min/session, at a high workload, corresponding to 80–90% of
maximal heart rate and according to individual capabilities. The
second part of the training session comprised similar resistance
training, as described in the HITR program.
Outcome Measures
Biopsy Collection and Preparation
To investigate muscle fiber SC, myonuclei, central nuclei content
as well as fiber CSA, muscle biopsies form the middle part
of the m. Vastus Lateralis (Bergström needle technique) of
the weakest leg (see isometric muscle strength measurements)
were collected by an experienced medical doctor. The post-
intervention biopsy was taken 2–3 cm proximal to the biopsy
taken at baseline. Muscle samples were immediately mounted
with Tissue-Tek, frozen in isopentane cooled with liquid nitrogen
and stored at −80◦C, until further analysis. The cross-sections
of the biopsies, collected at baseline and after 12 weeks, were
processed simultaneously.
Satellite Cell, Myonuclei, and Central Nuclei Analysis
Muscle biopsy sections were fixed in Histofix (Histolab,
Gothenborg, Sweden) followed by 1.5 h in blocking buffer (0.2%
Triton-X, 2% BSA, 5% FBS, 2% goat serum, and 0.1% sodium
azide). The sections were incubated overnight at 4◦C with
primary antibody for Pax7 (1:500; cat. no MO15020, Neuromics,
Edina, MN, USA), followed by 1.5 h in secondary Alexa Fluor
568 goat anti-mouse antibody (1:200; Molecular Probes, cat
no. A11034, Invitrogen A/S, Taastrup, Denmark). Following
this, the sections were incubated with primary antibodies for
Type I myosin [1:500; cat. no. A4.951, Developmental Studies
Hybridoma Bank (DSHB), IA, USA] and laminin (1:500; cat. no.
Z0097, Dako Norden) for 2 h and secondary Alexa Fluor 488
goat anti-mouse green and Alexa Fluor 488 goat anti-rabbit green
(1:500; Molecular Probes, cat no. A11031 and cat no. A11034,
Invitrogen A/S, Taastrup, Denmark) antibodies for 1 h. Finally,
a mounting media containing 4′,6-Diamidino-2-phenylindole
(DAPI) was utilized to visualize nuclei (Molecular Probes Prolog
Gold anti-fade reagent, cat. no. P36935, Invitrogen A/S) and
samples were stored at −20◦C until final analyses. Staining was
verified using appropriate negative controls to ensure specificity.
Images were obtained at 20x magnification using a Leica
DM2000 microscope (Leica, Stockholm, Sweden) and a Leica Hi-
resolution Color DFC camera (Leica, Stockholm, Sweden). The
number of Pax7 positive (Pax7+) cells (SCs) associated with type
I (A4.951+) or type II (A4.951−) fibers was quantified separately
and expressed relative to the total number of type I or II fibers
and fiber area (SC/mm2). To ensure reliable numbers of SCs,
in accordance with Mackey et al. (2009), we counted a mean of
246± 3 fibers on each biopsy.
Finally, in accordance with Bruusgaard et al. (2012), we
utilized these sections to quantify total sublaminar nuclei
(assumed to be myonuclei) by only counting Pax7 negative nuclei
with a visible geometric center within the basal lamina to ensure
that non-myonuclei were not counted. When located centrally in
the myofiber the nuclei were enumerated as a central nuclei. The
myonuclei and central nuclei content from total type I and type
II fibers were enumerated and normalized to the fiber number.
Initially two individuals performed the SC and myonuclei
quantifications on the same sections to ensure appropriate
quantifications. Following this, one individual, who was blinded
for subject identity, performed all SC, and myonuclei/central
nuclei quantifications.
Muscle Fiber CSA and Proportion
The fiber type specific CSA (fCSA) differences between MS and
HC as well as before and after training have been reported
previously (Wens et al., 2014, 2015). In brief, mean fCSA, as
well as fCSA of type I, II, and IIa fibers were approximately 18%
smaller in MS patients, compared to HC. Interestingly, 12 weeks
of exercise was able to reverse mean fCSA, as well as fCSA of type
I, II, and IIa fibers (Wens et al., 2014, 2015).
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In the present paper we utilized the fiber CSA from type I and
type II fibers as a second normalization strategy to account for
the potential influence of fiber size on the SC content. To briefly
describe the fiber area measurements, serial transverse sections (9
µm) from the obtained muscle samples were cut at −20◦C and
stained by means of ATPase histochemistry, after preincubation
at pH 4.4, 4.6, and 10.3, essentially following the procedure of
Brooke and Kaiser (Brooke and Kaiser, 1970). The serial sections
were visualized and analyzed using a Leica DM2000 microscope
(Leica, Stockholm, Sweden) and a Leica Hi-resolution Color
DFC camera (Leica, Stockholm, Sweden) combined with image-
analysis software (Leica Qwin ver. 3, Leica, Stockholm, Sweden).
A fiber mask of the stained sections was drawn automatically and
manually fitted to the cell borders of the selected fibers. Only
fibers cut perpendicularly to their longitudinal axis were used for
the determination of fiber size. Calculation of the fiber CSA for
the SC normalizations was performed only for type I and type II
(IIa+IIx) muscle fiber phenotypes. SCs in type I and II fibers were
normalized to type I and II fiber CSA, respectively [SCs × (mm2
fCSA)−1)]. Additionally, themyonuclear domain size (µm2 fCSA
×myonuclei−1) was calculated for type I and II fibers.
Muscle Tissue Fibrosis and Lipid Content
To evaluatemuscle fibrotic tissue content we quantifiedN-acetyl-
d-glucosamine content in accordance with previous studies (Fry
et al., 2014a, 2015). Sections were fixed 4min in Histofix and
incubated for 1 h with Alexa Fluor 488 conjugated Wheat Germ
Agglutinin (5 µg/ml, cat no. W11261, Invitrogen A/S). For
lipid quantification we stained the section in accordance with
previously published protocols (Mehlem et al., 2013). In brief,
Oil-Red-O (Direct Red 80, lot# MKBP5683V, Sigma-Aldrich,
Copenhagen, DK) working solution was prepared from 15 ml
of stock solution (2.5 g Oil-Red-O, 400ml 99% isopropyl) and
10 ml water, left to fridge for 10 min at 4◦C, and filtered
through 45-µm filter. The muscle sections were stained for 10
min in the working solution rinsed for 40 min in running tap-
water and mounted in pertex medium (Pertex, lot# 03649935,
CellPath, UK).
For quantification of fibrosis and lipids, five random images
from each biopsy were collected and analyzed using the threshold
and area quantification (in mm2) function in ImageJ. To account
for changes in fiber size, for the fibrosis stain, the area was
normalized to fiber number. Due to lack of sufficient sample
quality in some biopsies the number of included samples in this
analysis was somewhat smaller than for the SC analysis (n= 9–16
per group/time-point).
Statistical Analysis
Following check for normality using qq-plots and histogram
inspection and tests of equal variance (Bartletts test) the data
were expressed as mean ± SEM in text or as individual values
with mean bars and SEM in figures. The central nuclei data
were displayed as individual plots and median bars. Baseline
comparison betweenMS andHCwere performed using unpaired
t-test or Wilcoxon-Mann-Whitney test (only for central nuclei).
Differences in SCs, myonuclei, myonuclear domain between type
FIGURE 1 | Representative image of a muscle cross-section stained
for Pax7 (red), MCH-I (green), laminin (green), and nuclei (DAPI; blue).
White cones indicates the location of the Pax7+ satellite cells beneth the basal
lamina of two type II fibers (MHC−) and one type I fiber (MHC+). Yellow cones
indicate nuclei identified as myonuclei (i.e., Pax7− nuclei beneath the basal
lamina). Scale bar is 50 µm.
I and II fibers were conducted using a paired t-test while a
Wilcoxon-Mann-Whitney test was utilized for central nuclei.
The effect of time (Pre vs. Post) and group (HITR vs. HCTR)
and their interaction on dependent variables was assessed using
a mixed-effect linear model with repeated measures for time
using subject id as a random effect variable. This analysis
revealed no effect of group (HITR vs. HCTR) on any of the
dependent variables. Since no effects were observed and to
enhance the clarity of the paper and the power of the data the
two training groups were merged and only the effect of time was
examined (i.e., overall effect of training in general). As described
in the section above the central nuclei data showed a non-
parametric distribution and to examine the effect of training in
general we performed aWilcoxon-Mann-Whitney test on the two
training groups collapsed. To describe the association between
SC content, myonuclei, and single fCSA, a Pearson product-
moment correlation analysis was employed on pre- (MS and
HC combined) and post-(MS only) training data separately. The
alpha level was set to p ≤ 0.05. All statistical analyses were
performed using Stata (Stata v 12.0, StataCorp LP, TX, USA).
RESULTS
Satellite Cells, Myonuclei, and Central
Nuclei; MS vs. HC
A representative image of Pax7+ cells localized beneath the basal
lamina (i.e., SCs) of type I (MHC-I+) or type II (MHC-I−) fibers
as well as sublaminar Pax7− nuclei (i.e., myonuclei) is provided
in Figure 1.
At baseline the SCs per fiber and SCs per mm2 fiber area in
type I as well as type II fibers was similar between MS patients
and HC (Figures 2A,B). When expressed as SCs per fiber the SC
content of type II fibers was 119 ± 39% (p < 0.01) and 69 ±
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FIGURE 2 | Satellite cells (SCs) associated with type I or II fibers expressed per fiber (A) or per mm2 fiber area (B), myonuclei per fiber (C), and central
nuclei per fiber (D) evaluated from biopsies obtained from patients with multiple sclerosis (MS) and from healthy controls (HC). Data are presented as
individual values and mean ± SEM (A–C) or individual data-points and median bar (D). Significant differences between type I and type II fibers are denoted by **p <
0.05 or **p < 0.01.
21% (p < 0.05) lower compared to type I fibers, in MS and HC,
respectively. Conversely, when expressed as SCs per mm2 fiber
area only MS displayed a 72 ± 21% (p < 0.05) lower SC content
in type II fibers compared to type I fibers.
As for myonuclei no significant differences were observed
betweenMS and HC, (p= 0.15, Figure 2C). In contrast to SCs no
differences in myonuclear content were observed between fiber
types in neither MS nor HC. The myonuclear domain (fCSA
× myonuclei−1) was greater in type I (4568 ± 244 µm2 ×
myonuclei−1) as compared to type II fibers (3829 ± 229 µm2 ×
myonuclei−1) in MS and HC combined (p < 0.01), whereas no
group differences were observed.
The content of central nuclei (an indicator of myofiber
regeneration/remodeling) in type I or II fibers was not different
between MS and HC (Figure 2D). However, a difference in
central nuclei content between type I and II fibers was observed
in MS (p < 0.05) but not in HC.
Satellite Cells, Myonuclei, and Central
Nuclei; Effect of Training in MS
The training intervention in MS patients elicited an increase in
SCs per fiber associated with type II fibers of 165 ± 68% (p <
0.05, Figure 3A). In contrast no changes were observed in SCs
per fiber in type I fibers. Similarly, an increase of 135 ± 63% was
observed when expressed as SCs per mm2 fiber area in type II
fibers (p < 0.05, Figure 3B), whereas no changes were found in
SCs per mm2 fiber area in type I fibers.
The myonuclear content of type II fibers displayed a tendency
toward an increase of 35 ± 14% following training (p = 0.06,
Figure 3C), whereas no changes were observed in type I fibers.
No changes were observed in the size of the myonuclear domain
and the difference between the myonuclear domain size of type I
(4348 ± 402 µm2 ×myonuclei−1) and type II (3683 ± 399 µm2
×myonuclei−1) fibers persisted following training (p < 0.05).
No changes were observed in the number of central nuclei
of either type I or type II fibers (Figure 3D). In addition, no
differences were observed between type I and type II fibers at
post-training.
Skeletal Muscle Fibrosis and Lipid
Content; Effect of MS and Training
At baseline we observed a difference in muscle tissue fibrosis
(Figure 4A, p= 0.05) betweenMS (0.0011± 0.00013mm2/fiber)
and HC (0.00077± 0.000078mm2/fiber), whereas no differences
were detected from pre- to post-training in MS. As for lipid
content we found no differences at baseline between MS and HC,
whereas we did detect a significant increase post-training in MS
of 117 ± 37% (Figure 4C, p < 0.05). Representative images for
N-acetyl-d-glucosamine and Oil-Red-O staining’s are shown in
Figures 4B,D.
Association between Fiber Size, Satellite
Cell, and Myonuclear Content
To investigate the association between fiber CSA and SC content
we performed a correlation analysis on pre- as well as post-
training data. At pre-training (both MS and HC included)
the fiber CSA of type I and type II fibers was positively
associated with SC content (Figures 5A,B). Conversely, at post-
training only type II fCSA was positively associated SC content
(Figures 5C,D). Notably, in type II fibers the r2 increased
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FIGURE 3 | Satellite cells (SCs) associated with type I or II fibers expressed per fiber (A) or per mm2 fiber area (B), myonuclei per fiber (C), and central
nuclei per fiber (D) evaluated from biopsies obtained pre- and post-training in multiple sclerosis patients. Data are presented as individual values and
mean ± SEM (A–C) or individual data-points and median bar (D). Significant differences from pre to post are denoted by *p < 0.05 and tendencies by (*) p = 0.06.
from 0.2 at pre-training to 0.5 at post-training. Furthermore,
we assessed whether SC or myonuclei content at baseline was
associated with the increase in CSA for type I or type II fibers.
We observed a tendency for myonuclei content in type II fibers at
baseline to be associated with type II fiber growth (r2 = 0.31, p=
0.06), whereas no other significant associations were observed
(data not shown). Finally, we observed no associations between
the increase in SC content, the accretion of myonuclei, and the
myofiber growth (data not shown).
DISCUSSION
The skeletal muscle stem cells (i.e., SCs) are instrumental
for muscle regenerative capacity, health, and function. In
consequence, a thorough understanding of SC regulation and
function in neurodegenerative disorders such as MS, may add
important knowledge for the preservation of skeletal musclemass
and quality inMS, and in neurodegenerative disorders in general.
The main findings of the present study is that (1) a lower SC
content in type II compared to type I fibers is observed in MS
as well as in healthy age-matched controls, (2) the decreased
type II fiber size in MS is associated with a trend toward a
lower myonuclei content and increased tissue fibrosis, and (3)
combined resistance and cardiovascular training can increase the
SC and myonuclei content in type II fibers.
Satellite Cells and Myonuclei in Healthy
Controls vs. MS
In the present study we observed a lower SC content per fiber
in type II compared to type I fibers both in MS and healthy
controls. The content of SCs per fiber is known to decline during
aging in a fiber type specific manner (Verdijk et al., 2009a, 2013;
McKay et al., 2012; Mackey et al., 2013); i.e., with type II fibers
selectively demonstrating a lower number of SCs, even when
normalizing for fiber size (Verdijk et al., 2009a; Mackey et al.,
2013). It is not yet well-defined at which time-point during aging
this fiber type difference becomes detectable, however, earlier
studies have reported fiber type differences in SC content in both
elderly (i.e., age 50–69) and senescent (i.e., age >70) subjects
(Verdijk et al., 2013). The healthy controls andMS patients in the
present study were slightly younger (i.e., mean age of 47.5 and
45.7, respectively) and our findings thus indicate that aging or
inactivity per semay explain the lower SC content per fiber in type
II fibers, while no significant effect ofMS per sewas observed. The
effect of chronic disease on SC content in vivo in humans is only
sparsely described (Snijders et al., 2011; Beenakker et al., 2012;
Molsted et al., 2015) and none of these have included a healthy
age-matched control group. Thus, while both type II diabetic
patients (Snijders et al., 2011) and dialysis patients (Molsted
et al., 2015) were reported to have a reduced SC content per
fiber in type II compared to type I fibers, it is unclear if these
fiber type differences were related to the disease per se and/or
aging. Since both studies reported a mean patient age >50 years,
the reported fiber type difference may in fact predominantly
be related to aging (Verdijk et al., 2013) rather that to the
specific pathological condition, as our data on MS vs. healthy
controls indicate.
In addition to aging, the decline in type II fiber SCs
may partially be explained by inactivity. In a recent study
master athletes (i.e., athletes obtaining a major exercise volume
throughout life) were observed to maintain a similar content
of SCs in type I and type II fibers when normalizing to fiber
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FIGURE 4 | Muscle tissue area (mm2) occupied by connective tissue/fibrosis per fiber (A) and lipid content (C) evaluated from biopsies obtained from
healthy controls (HC), and multiple sclerosis patients (MS) pre- and post-training. Data are presented as individual values and mean ± SEM. Significant
differences from pre to post are denoted by *p < 0.05. Representative images of connective tissue stain (N-acetyl-d-glucosamine stain) and lipids (Oil-Red-O) area
shown in (B) and (D), respectively.
area (Mackey et al., 2013). Furthermore, inactive young (i.e.,
mean age 24) as well as inactive elderly (i.e., mean age 66) were
reported to have a lower SC content in type II compared to type I
fibers when normalized to fiber area, suggesting that inactivity
per se may drive the lower SC in type II fibers, irrespective
of aging (Mackey et al., 2013). Interestingly, in the present
study we observed a reduction in SCs per fiber area in type II
compared to type I fibers in MS patients whereas no differences
were detected in healthy controls, although no significant group
difference between MS and healthy controls could be detected.
As previously reported, MS patients display a lower type II fiber
area compared to healthy controls (Wens et al., 2014) matched
for age and BMI and with no questionnaire reported differences
in activity levels (data not shown). Therefore, the lower type II
fiber SC content when normalized to fiber size may be related to
MS rather than aging or inactivity. In addition, we observed a
greater degree of connective tissue/fibrosis (as evaluated by the
N-acetyl-d-glucosamine staining) in MS patients compared to
controls, whereas no differences were observed in lipid content.
The mechanisms underlying these findings cannot be elucidated
from the present study, however, earlier studies have reportedMS
to be associated with a greater level of systemic pro-inflammatory
cytokines such as tumor necrosis factors alpha (TNFα) compared
to healthy controls (Martins et al., 2011). When TNFα, which
during normal muscle regeneration is transiently released from
classically activated (pro-inflammatory) macrophages (Arnold
et al., 2007), is chronically secreted and elevated this may
hamper SC self-renewal through epigenetic repression of Pax7
expression (Palacios et al., 2010). Conversely, TNFα has recently
been suggested to prevent muscle tissue fibrosis through
induction of fibro-adipogenic progenitor apoptosis (Lemos et al.,
2015) whereas TGFβ1 increased fibro-adipogenic progenitor
differentiation into extra-cellular matrix producing cells. The
increased connective tissue/fibrosis in MS vs. controls may
therefore indicate decreased levels of TNFα/increased levels of
TGFβ1, or at least a dysfunctional regulation of these cytokines
compared to healthy controls. However, in the present study
we did not measure TNFα or TGFβ1 and furthermore our
speculation will require more studies with greater statistical
power before any inferences can be suggested.
In regards to the previously reported atrophy of type II fibers
in MS patients (Wens et al., 2014), we also observed a trend
toward a lower content of myonuclei specifically in type II fibers
in MS patients. Thus, the myofiber atrophy may be associated
with a lower myonuclear content, which would serve to maintain
the same myonuclear domain size (fCSA/myonuclei). Moreover,
we did also observe a significant association between fCSA
and SC content in both fiber types at baseline, suggesting
that fiber size may partly explain the SC content or vice
versa.
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FIGURE 5 | Correlations and scatter plots of type I and type II fiber cross-sectional area (CSA) and satellite cell content at pre-training (A,B) and
post-training (C,D). Dashed lines denote the 95% confidence intervals. Pearson correlation coefficients (r2) and significance are shown for each correlation.
Effect of Training on Satellite Cell Content
and Myonuclei Accretion in MS Patients
Following combined cardio vascular and resistance training
the SC content per fiber as well as per fCSA increased
in MS patients along with an increase in the myonuclear
content of type II fibers. Resistance training has previously
been shown to increase fCSA, SC, and myonuclear content
in both young and old subjects (Kadi et al., 2004; Petrella
et al., 2006; Verdijk et al., 2009a; Mackey et al., 2010; Farup
et al., 2014). In elderly subjects the selective type II fiber
atrophy appears to be partly reversible with resistance training
(Kryger and Andersen, 2007; Verdijk et al., 2009a,b) which is
associated with a selective increase in SCs in type II fibers
(Verdijk et al., 2009a). Interestingly, high intensity endurance
training can also increase the SC content of type II fibers
and increase the content of SCs expressing the myogenic
differentiation factor; MyoD (Verney et al., 2008; Hoedt et al.,
2015). Although endurance training may induce minor increases
in myofiber size, these studies indicate that SC content and
activity can increase without significant changes in myofiber
size (Verney et al., 2008; Joanisse et al., 2013; Hoedt et al.,
2015). Consequently, the increase in SC content in response
to exercise is not necessarily related to myofiber hypertrophy,
although previous studies have indicated that pre-training SC
content may predict myofiber hypertrophy potential (Petrella
et al., 2006, 2008). We did observe a positive association
between myonuclei content in type II fibers at baseline and
the type II fiber hypertrophy observed post-training, however,
we found no association between SC content at baseline
and myofiber growth in contrast to previous studies (Petrella
et al., 2008). Since the MS patients in the present study
performed both endurance and resistance exercise this may
confound these correlation analyses, as both can influence SC
content, whereas resistance exercise is the primary inducer of
myofiber growth.
Very few studies have, to our knowledge, investigated the
effect of resistance training on SC content in patients suffering
from chronic diseases. In patients undergoing dialysis no changes
were reported in type II fiber SC content following 16 weeks
of resistance training (Molsted et al., 2015). However, in the
latter study the authors did report an increase in the myonuclear
content of type II fibers suggesting that SCs had proliferated and
committed to the myogenic differentiation program at an earlier
time-point (Molsted et al., 2015). In support, we observed an
increase in the content of myonuclei in type II fibers, which was
accompanied by an increase in the SC content of type II fibers. Of
note, the increase in type II fiber SC resulted in an elimination
of the fiber type difference observed at baseline between type
I and type II fibers, in accordance with earlier results on
resistance training in elderly subjects (Verdijk et al., 2009a).
We did not observe any changes in connective tissue/fibrosis
content; however, we did find an increased in lipid (Oil-Red-O
stain). This is most likely explained by increased lipid storage
in the myofibers (intracellular lipids) in response to training, as
observed in endurance athletes (Goodpaster et al., 2001; Amati
et al., 2011), in contrast to extracellular lipid (e.g., adipocytes).
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Clinical Implications
The present findings suggest that the SC pool may decrease
with age or inactivity whereas any direct effect of MS is
less clear. Interestingly, high intensity training in MS patients
can, in part, reverse this age, inactivity or MS related decline
and help preserve muscle mechanical and metabolic function.
Importantly, our data indicate that the SCs are able to
both proliferate and differentiate to support the accretion of
myonuclei and thereby providing additional transcriptional
capacity to assist the type II fiber growth. Collectively, this
suggests an intact functionality of the SCs in MS patients.
Moreover, the preserved function of the SC pool suggests that
MS patients have maintained their ability to support muscle
hypertrophy (as observed in the present study), but potentially
also the regenerative capacity when experiencing a more severe
muscle injury or insult. Immobilization for shorter or longer
periods is often experienced during aging in general, but also
during neurodegenerative diseases. Following immobilization
induced atrophy, the inability of the SC pool to proliferate is
associated with impaired regrowth in elderly subjects (Suetta
et al., 2013), suggesting that the preserved function of the
SCs in MS is important for the ability to recover following
immobilization. Collectively, combined cardio vascular and
resistance training provide a feasible strategy to increase type
II fiber size while also increasing the muscle stem cell pool,
which combined may support MS patients during recovery
from muscle trauma, immobilization or simply deconditioning.
However, when interpreting the present study it should be
kept in mind that the sample size of the study is somewhat
limited.
CONCLUSION
In conclusion, we report thatMS patients have a lower SC content
in type II compared to type I fibers, however, this reduction
was also observed in a healthy age matched control group.
Furthermore, high intensity training reversed the reduction in
type II fiber SC and induces differentiation of SC to provide
additional myonuclei to the post-mitotic myofibers. Collectively,
the SC pool in MS patients appear to maintain proliferative and
differentiation capacity, which can be stimulated through high
intensity training.
AUTHOR CONTRIBUTIONS
Conception and design of research; IW, UD, BE conducted
clinical trial; IW, CK performed experiments; JF, IW analyzed
data; JF, IW interpreted results of experiments; JF, UD, IWdrafted
manuscript; JF, UD, IW edited and revised manuscript; JF, UD,
CK, BE, IW approved final version of manuscript; JF, UD, CK,
BE, IW.
FUNDING
This work was supported by MS Fund, Limburg, Flanders,
Belgium and the Danish Council for Independent
Research/Medical Sciences, 5053-00195B.
REFERENCES
Adams, G. R., Caiozzo, V. J., Haddad, F., and Baldwin, K. M. (2002). Cellular and
molecular responses to increased skeletal muscle loading after irradiation. Am.
J. Physiol. Cell Physiol. 283, C1182–1195. doi: 10.1152/ajpcell.00173.2002
Amati, F., Dube, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P.,
Coen, P. M., et al. (2011). Skeletal muscle triglycerides, diacylglycerols, and
ceramides in insulin resistance: another paradox in endurance-trained athletes?
Diabetes 60, 2588–2597. doi: 10.2337/db10-1221
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., Van Rooijen, N., Plonquet, A.,
et al. (2007). Inflammatory monocytes recruited after skeletal muscle injury
switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med.
204, 1057–1069. doi: 10.1084/jem.20070075
Beenakker, K. G., Duijnisveld, B. J., Van Der Linden, H. M., Visser, C. P.,
Westendorp, R. G., Butler-Brown, G., et al. (2012). Muscle characteristics in
patients with chronic systemic inflammation. Muscle Nerve 46, 204–209. doi:
10.1002/mus.23291
Biressi, S., and Gopinath, S. D. (2015). The quasi-parallel lives of satellite cells and
atrophying muscle. Front. Aging Neurosci. 7:140. doi: 10.3389/fnagi.2015.00140
Blaauw, B., and Reggiani, C. (2014). The role of satellite cells in muscle
hypertrophy. J. Muscle Res. Cell Motil. 35, 3–10. doi: 10.1007/s10974-014-
9376-y
Brack, A. S., and Rando, T. A. (2012). Tissue-specific stem cells: lessons
from the skeletal muscle satellite cell. Cell Stem Cell 10, 504–514. doi:
10.1016/j.stem.2012.04.001
Brooke, M. H., and Kaiser, K. K. (1970). Muscle fiber types: how many and what
kind? Arch. Neurol. 23, 369–379. doi: 10.1001/archneur.1970.00480280083010
Bruusgaard, J. C., Egner, I. M., Larsen, T. K., Dupre-Aucouturier, S., Desplanches,
D., and Gundersen, K. (2012). No change in myonuclear number during
muscle unloading and reloading. J. Appl. Physiol. 113, 290–296. doi:
10.1152/japplphysiol.00436.2012
Carlson, M. E., Suetta, C., Conboy, M. J., Aagaard, P., Mackey, A., Kjaer, M., et al.
(2009). Molecular aging and rejuvenation of human muscle stem cells. EMBO
Mol. Med. 1, 381–391. doi: 10.1002/emmm.200900045
Chakkalakal, J. V., Jones, K. M., Basson, M. A., and Brack, A. S. (2012). The
aged niche disrupts muscle stem cell quiescence. Nature 490, 355–360. doi:
10.1038/nature11438
Compston, A., and Coles, A. (2002).Multiple sclerosis. Lancet 359, 1221–1231. doi:
10.1016/S0140-6736(02)08220-X
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., and
Rando, T. A. (2005). Rejuvenation of aged progenitor cells by exposure to a
young systemic environment. Nature 433, 760–764. doi: 10.1038/nature03260
Conley, K. E., Cress, M. E., Jubrias, S. A., Esselman, P. C., and Odderson, I.
R. (1995). From muscle properties to human performance, using magnetic
resonance. J. Gerontol. A Biol. Sci. Med. Sci. 50 Spec No:35–40.
Cosgrove, B. D., Gilbert, P. M., Porpiglia, E., Mourkioti, F., Lee, S. P., Corbel,
S. Y., et al. (2014). Rejuvenation of the muscle stem cell population restores
strength to injured aged muscles. Nat. Med. 20, 255–264. doi: 10.1038/
nm.3464
Dalgas, U., Stenager, E., Jakobsen, J., Petersen, T., Overgaard, K., and
Ingemann-Hansen, T. (2010). Muscle fiber size increases following
resistance training in multiple sclerosis. Mult. Scler. J. 10, 1367–1376.
doi: 10.1177/1352458510377222
Doring, A., Pfueller, C. F., Paul, F., and Dorr, J. (2011). Exercise in multiple
sclerosis—an integral component of disease management. EPMA J. 3, 2. doi:
10.1007/s13167-011-0136-4
Elabd, C., Cousin, W., Upadhyayula, P., Chen, R. Y., Chooljian, M. S., Li,
J., et al. (2014). Oxytocin is an age-specific circulating hormone that is
necessary for muscle maintenance and regeneration. Nat. Commun. 5, 4082.
doi: 10.1038/ncomms5082
Farup, J., Kjolhede, T., Sorensen, H., Dalgas, U., Moller, A. B., Vestergaard,
P. F., et al. (2012). Muscle morphological and strength adaptations to
Frontiers in Physiology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 193
Farup et al. Satellite Cells and Multiple Sclerosis
endurance vs. resistance training. J. Strength Cond. Res. 26, 398–407. doi:
10.1519/JSC.0b013e318225a26f
Farup, J., Rahbek, S. K., Riis, S., Vendelbo, M. H., Paoli, F., and Vissing, K. (2014).
Influence of exercise contractionmode and protein supplementation on human
skeletal muscle satellite cell content and muscle fiber growth. J. Appl. Physiol.
117, 898–909. doi: 10.1152/japplphysiol.00261.2014
Folland, J. P., and Williams, A. G. (2007). The adaptations to strength training :
morphological and neurological contributions to increased strength. Sports
Med. 37, 145–168. doi: 10.2165/00007256-200737020-00004
Fry, C. S., Lee, J. D., Jackson, J. R., Kirby, T. J., Stasko, S. A., Liu, H., et al. (2014a).
Regulation of the muscle fiber microenvironment by activated satellite cells
during hypertrophy. FASEB J. 28, 1654–1665. doi: 10.1096/fj.13-239426
Fry, C. S., Lee, J. D., Mula, J., Kirby, T. J., Jackson, J. R., Liu, F., et al. (2015).
Inducible depletion of satellite cells in adult, sedentary mice impairs muscle
regenerative capacity without affecting sarcopenia. Nat. Med. 21, 76–80. doi:
10.1038/nm.3710
Fry, C. S., Noehren, B., Mula, J., Ubele, M. F., Westgate, P. M., Kern, P. A.,
et al. (2014b). Fibre type-specific satellite cell response to aerobic training in
sedentary adults. J. Physiol. 592, 2625–2635. doi: 10.1113/jphysiol.2014.271288
Goodpaster, B. H., He, J., Watkins, S., and Kelley, D. E. (2001). Skeletal
muscle lipid content and insulin resistance: evidence for a paradox in
endurance-trained athletes. J. Clin. Endocrinol. Metab. 86, 5755–5761. doi:
10.1210/jcem.86.12.8075
Guerci, A., Lahoute, C., Hebrard, S., Collard, L., Graindorge, D., Favier, M.,
et al. (2012). Srf-dependent paracrine signals produced by myofibers control
satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 15, 25–37. doi:
10.1016/j.cmet.2011.12.001
Hoedt, A., Christensen, B., Nellemann, B., Mikkelsen, U. R., Hansen, M.,
Schjerling, P., et al. (2015). Satellite cell response to erythropoietin treatment
and endurance training in healthy young men. J. Physiol. 594, 727–743. doi:
10.1113/JP271333
Joanisse, S., Gillen, J. B., Bellamy, L. M., Mckay, B. R., Tarnopolsky, M. A.,
Gibala, M. J., et al. (2013). Evidence for the contribution of muscle stem
cells to nonhypertrophic skeletal muscle remodeling in humans. FASEB J. 27,
4596–4605. doi: 10.1096/fj.13-229799
Kadi, F., Schjerling, P., Andersen, L. L., Charifi, N., Madsen, J. L., Christensen,
L. R., et al. (2004). The effects of heavy resistance training and detraining
on satellite cells in human skeletal muscles. J. Physiol. 558, 1005–1012. doi:
10.1113/jphysiol.2004.065904
Kryger, A. I., and Andersen, J. L. (2007). Resistance training in the oldest
old: consequences for muscle strength, fiber types, fiber size, and MHC
isoforms. Scand. J. Med. Sci. Sports 17, 422–430. doi: 10.1111/j.1600-0838.2006.
00575.x
Lemos, D. R., Babaeijandaghi, F., Low, M., Chang, C. K., Lee, S. T., Fiore, D.,
et al. (2015). Nilotinib reduces muscle fibrosis in chronic muscle injury by
promoting TNF-mediated apoptosis of fibro/adipogenic progenitors.Nat. Med.
21, 786–794. doi: 10.1038/nm.3869
Lepper, C., Partridge, T. A., and Fan, C. M. (2011). An absolute requirement
for Pax7-positive satellite cells in acute injury-induced skeletal muscle
regeneration. Development 138, 3639–3646. doi: 10.1242/dev.067595
Mackey, A. L., Andersen, L. L., Frandsen, U., and Sjogaard, G. (2011). Strength
training increases the size of the satellite cell pool in type I and II fibres of
chronically painful trapezius muscle in females. J. Physiol. 589, 5503–5515. doi:
10.1113/jphysiol.2011.217885
Mackey, A. L., Holm, L., Reitelseder, S., Pedersen, T. G., Doessing, S., Kadi, F., et al.
(2010). Myogenic response of human skeletal muscle to 12 weeks of resistance
training at light loading intensity. Scand. J. Med. Sci. Sports 21, 773–782. doi:
10.1111/j.1600-0838.2010.01178.x
Mackey, A. L., Karlsen, A., Couppe, C., Mikkelsen, U. R., Nielsen, R. H.,
Magnusson, S. P., et al. (2013). Differential satellite cell density of type I and
II fibres with lifelong endurance running in old men. Acta Physiol. (Oxf). 210,
612–624. doi: 10.1111/apha.12195
Mackey, A. L., Kjaer, M., Charifi, N., Henriksson, J., Bojsen-Moller, J., Holm, L.,
et al. (2009). Assessment of satellite cell number and activity status in human
skeletal muscle biopsies.Muscle Nerve 40, 455–465. doi: 10.1002/mus.21369
Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L.,
et al. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet.
Muscle 1:21. doi: 10.1186/2044-5040-1-21
Martins, T. B., Rose, J. W., Jaskowski, T. D., Wilson, A. R., Husebye,
D., Seraj, H. S., et al. (2011). Analysis of proinflammatory and anti-
inflammatory cytokine serum concentrations in patients with multiple sclerosis
by using a multiplexed immunoassay. Am. J. Clin. Pathol. 136, 696–704. doi:
10.1309/AJCP7UBK8IBVMVNR
Mauro, A. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol.
9, 493–495. doi: 10.1083/jcb.9.2.493
McCarthy, J. J., Mula, J., Miyazaki, M., Erfani, R., Garrison, K., Farooqui, A.
B., et al. (2011). Effective fiber hypertrophy in satellite cell-depleted skeletal
muscle. Development 138, 3657–3666. doi: 10.1242/dev.068858
McKay, B. R., Ogborn, D. I., Bellamy, L. M., Tarnopolsky, M. A., and Parise,
G. (2012). Myostatin is associated with age-related human muscle stem cell
dysfunction. FASEB J. 26, 2509–2521. doi: 10.1096/fj.11-198663
Mehlem, A., Hagberg, C. E., Muhl, L., Eriksson, U., and Falkevall, A. (2013).
Imaging of neutral lipids by oil red O for analyzing the metabolic status in
health and disease. Nat. Protoc. 8, 1149–1154. doi: 10.1038/nprot.2013.055
Miller, A., and Dishon, S. (2006). Health-related quality of life in multiple sclerosis:
the impact of disability, gender and employment status. Qual. Life Res. 15,
259–271. doi: 10.1007/s11136-005-0891-6
Molsted, S., Andersen, J. L., Harrison, A. P., Eidemak, I., and Mackey, A. L.
(2015). The fiber-type specific response of skeletal muscle satellite cells to high-
intensity resistance training in dialysis patients.Muscle Nerve 52, 736–745. doi:
10.1002/mus.24633
Montarras, D., L’honore, A., and Buckingham, M. (2013). Lying low but ready
for action: the quiescent muscle satellite cell. FEBS J. 280, 4036–4050. doi:
10.1111/febs.12372
Olsen, S., Aagaard, P., Kadi, F., Tufekovic, G., Verney, J., Olesen, J. L., et al. (2006).
Creatine supplementation augments the increase in satellite cell and myonuclei
number in human skeletal muscle induced by strength training. J. Physiol. 573,
525–534. doi: 10.1113/jphysiol.2006.107359
Palacios, D., Mozzetta, C., Consalvi, S., Caretti, G., Saccone, V., Proserpio, V., et al.
(2010). TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links
inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 7,
455–469. doi: 10.1016/j.stem.2010.08.013
Petrella, J. K., Kim, J. S., Cross, J. M., Kosek, D. J., and Bamman, M. M. (2006).
Efficacy of myonuclear addition may explain differential myofiber growth
among resistance-trained young and older men and women. Am. J. Physiol.
Endocrinol. Metab. 291, E937–E946. doi: 10.1152/ajpendo.00190.2006
Petrella, J. K., Kim, J. S., Mayhew, D. L., Cross, J. M., and Bamman, M. M. (2008).
Potentmyofiber hypertrophy during resistance training in humans is associated
with satellite cell-mediated myonuclear addition: a cluster analysis. J. Appl.
Physiol. 104, 1736–1742. doi: 10.1152/japplphysiol.01215.2007
Price, F. D., VonMaltzahn, J., Bentzinger, C. F., Dumont, N. A., Yin, H., Chang, N.
C., et al. (2014). Inhibition of JAK-STAT signaling stimulates adult satellite cell
function. Nat. Med. 20, 1174–1181. doi: 10.1038/nm.3655
Sambasivan, R., Yao, R., Kissenpfennig, A., Van Wittenberghe, L., Paldi,
A., Gayraud-Morel, B., et al. (2011). Pax7-expressing satellite cells are
indispensable for adult skeletal muscle regeneration. Development 138,
3647–3656. doi: 10.1242/dev.067587
Sinha, M., Jang, Y. C., Oh, J., Khong, D., Wu, E. Y., Manohar, R., et al. (2014).
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse
skeletal muscle. Science 344, 649–652. doi: 10.1126/science.1251152
Snijders, T., Verdijk, L. B., Beelen, M., Mckay, B. R., Parise, G., Kadi, F.,
et al. (2012). A single bout of exercise activates skeletal muscle satellite
cells during subsequent overnight recovery. Exp. Physiol. 97, 762–773. doi:
10.1113/expphysiol.2011.063313
Snijders, T., Verdijk, L. B., Hansen, D., Dendale, P., and Van Loon, L. J. (2011).
Continuous endurance-type exercise training does not modulate satellite cell
content in obese type 2 diabetes patients. Muscle Nerve 43, 393–401. doi:
10.1002/mus.21891
Snijders, T., Verdijk, L. B., Mckay, B. R., Smeets, J. S. J., Van Kranenburg,
J., Groen, B. B. B., et al. (2013). Acute dietary protein intake restriction is
associated with changes in myostatin expression after a single bout of resistance
exercise in healthy young men. J. Nutr. 144, 137–145. doi: 10.3945/jn.113.1
83996
Snijders, T., Verdijk, L. B., andVan Loon, L. J. (2009). The impact of sarcopenia and
exercise training on skeletal muscle satellite cells. Ageing Res. Rev. 8, 328–338.
doi: 10.1016/j.arr.2009.05.003
Frontiers in Physiology | www.frontiersin.org 10 May 2016 | Volume 7 | Article 193
Farup et al. Satellite Cells and Multiple Sclerosis
Suetta, C., Frandsen, U., Mackey, A. L., Jensen, L., Hvid, L. G., Bayer, M. L.,
et al. (2013). Ageing is associated with diminished muscle re-growth and
myogenic precursor cell expansion early after immobility-induced atrophy in
human skeletal muscle. J. Physiol. 591, 3789–3804. doi: 10.1113/jphysiol.2013.2
57121
Theriault, M. E., Pare, M. E., Lemire, B. B., Maltais, F., and Debigare,
R. (2014). Regenerative defect in vastus lateralis muscle of patients with
chronic obstructive pulmonary disease. Respir. Res. 15:35. doi: 10.1186/1465-9
921-15-35
Thoumie, P., Lamotte, D., Cantalloube, S., Faucher, M., and Amarenco, G. (2005).
Motor determinants of gait in 100 ambulatory patients with multiple sclerosis.
Mult. Scler. 11, 485–491. doi: 10.1191/1352458505ms1176oa
Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S., and Tsuchida, K. (2010).
Mesenchymal progenitors distinct from satellite cells contribute to ectopic
fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143–152. doi:
10.1038/ncb2014
Verdijk, L. B., Gleeson, B. G., Jonkers, R. A., Meijer, K., Savelberg, H. H., Dendale,
P., et al. (2009a). Skeletal muscle hypertrophy following resistance training
is accompanied by a fiber type-specific increase in satellite cell content in
elderly men. J. Gerontol. A Biol. Sci. Med. Sci. 64, 332–339. doi: 10.1093/gerona/
gln050
Verdijk, L. B., Jonkers, R. A., Gleeson, B. G., Beelen, M., Meijer, K., Savelberg,
H. H., et al. (2009b). Protein supplementation before and after exercise does
not further augment skeletal muscle hypertrophy after resistance training
in elderly men. Am. J. Clin. Nutr. 89, 608–616. doi: 10.3945/ajcn.2008.
26626
Verdijk, L. B., Snijders, T., Drost, M., Delhaas, T., Kadi, F., and Van Loon, L.
J. (2013). Satellite cells in human skeletal muscle; from birth to old age. Age
(Dordr). 36, 545–558. doi: 10.1007/s11357-013-9583-2
Verney, J., Kadi, F., Charifi, N., Feasson, L., Saafi, M. A., Castells, J., et al. (2008).
Effects of combined lower body endurance and upper body resistance training
on the satellite cell pool in elderly subjects. Muscle Nerve 38, 1147–1154. doi:
10.1002/mus.21054
von Maltzahn, J., Jones, A. E., Parks, R. J., and Rudnicki, M. A. (2013).
Pax7 is critical for the normal function of satellite cells in adult skeletal
muscle. Proc. Natl. Acad. Sci. U.S.A. 110, 16474–16479. doi: 10.1073/pnas.1307
680110
Wens, I., Dalgas, U., Vandenabeele, F., Grevendonk, L., Verboven, K., Hansen,
D., et al. (2015). high intensity exercise in multiple sclerosis: effects on
muscle contractile characteristics and exercise capacity, a randomised
controlled trial. PLoS ONE 10:e0133697. doi: 10.1371/journal.pone.01
33697
Wens, I., Dalgas, U., Vandenabeele, F., Krekels, M., Grevendonk, L., and Eijnde, B.
O. (2014). Multiple sclerosis affects skeletal muscle characteristics. PLoS ONE
9:e108158. doi: 10.1371/journal.pone.0108158
Yin, H., Price, F., and Rudnicki, M. A. (2013). Satellite cells and the muscle stem
cell niche. Physiol. Rev. 93, 23–67. doi: 10.1152/physrev.00043.2011
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Farup, Dalgas, Keytsman, Eijnde andWens. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 193
